Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
0.4448
-0.0567 (-11.31%)
At close: Jun 9, 2026, 4:00 PM EDT
0.4500
+0.0052 (1.17%)
After-hours: Jun 9, 2026, 4:00 PM EDT
Nexalin Technology Market Cap
Nexalin Technology has a market cap or net worth of $9.15 million as of June 9, 2026. Its market cap has decreased by -55.59% in one year.
Market Cap
9.15M
Enterprise Value
7.24M
1-Year Change
-55.59%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since the IPO on September 16, 2022, Nexalin Technology's market cap has decreased from $16.38M to $9.15M, a decrease of -44.11%. That is a compound annual growth rate of -14.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 10.78M | 3.56% |
| Dec 31, 2025 | 10.41M | -70.68% |
| Dec 31, 2024 | 35.50M | 1,079.21% |
| Dec 29, 2023 | 3.01M | -44.79% |
| Dec 30, 2022 | 5.45M | -66.71% |
| Sep 16, 2022 | 16.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adagio Medical Holdings | 16.10M |
| Trinity Biotech | 13.77M |
| Vivos Therapeutics | 12.09M |
| VolitionRx | 11.01M |
| IceCure Medical | 9.85M |
| Phaos Technology Holdings (Cayman) Limited | 9.76M |
| Sintx Technologies | 8.94M |
| enVVeno Medical | 6.82M |